156 related articles for article (PubMed ID: 8387763)
1. Neurotensin regulates growth of human pancreatic cancer.
Ishizuka J; Townsend CM; Thompson JC
Ann Surg; 1993 May; 217(5):439-45; discussion 446. PubMed ID: 8387763
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692.
Iwase K; Evers BM; Hellmich MR; Kim HJ; Higashide S; Gully D; Thompson JC; Townsend CM
Cancer; 1997 May; 79(9):1787-93. PubMed ID: 9128997
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of neurotensin and neuromedin N on growth of human pancreatic cancer, MIA PaCa-2.
Sumi S; Evers BM; Townsend CM; Yoshinaga K; Uchida T; Murakami M; Sato K; Ishizuka J; Thompson JC
Surg Oncol; 1993 Oct; 2(5):267-72. PubMed ID: 7508319
[TBL] [Abstract][Full Text] [Related]
4. Neurotensin receptor-mediated inhibition of pancreatic cancer cell growth by the neurotensin antagonist SR 48692.
Herzig MC; Chapman WG; Sheridan A; Rake JB; Woynarowski JM
Anticancer Res; 1999; 19(1A):213-9. PubMed ID: 10226545
[TBL] [Abstract][Full Text] [Related]
5. Neurotensin-mediated activation of MAPK pathways and AP-1 binding in the human pancreatic cancer cell line, MIA PaCa-2.
Ehlers RA; Zhang Y; Hellmich MR; Evers BM
Biochem Biophys Res Commun; 2000 Mar; 269(3):704-8. PubMed ID: 10720480
[TBL] [Abstract][Full Text] [Related]
6. Neurotensin stimulates cyclic AMP formation in CHO-rNTR-10 cells expressing the cloned rat neurotensin receptor.
Yamada M; Yamada M; Watson MA; Richelson E
Eur J Pharmacol; 1993 Jan; 244(1):99-101. PubMed ID: 8380559
[TBL] [Abstract][Full Text] [Related]
7. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of SR 48692 sensitive neurotensin receptor in human pancreatic cancer cells, MIA PaCa-2.
Yamada M; Ohata H; Momose K; Yamada M; Richelson E
Res Commun Mol Pathol Pharmacol; 1995 Oct; 90(1):37-47. PubMed ID: 8581347
[TBL] [Abstract][Full Text] [Related]
9. G protein-coupled receptor signaling in human ductal pancreatic cancer cells: neurotensin responsiveness and mitogenic stimulation.
Ryder NM; Guha S; Hines OJ; Reber HA; Rozengurt E
J Cell Physiol; 2001 Jan; 186(1):53-64. PubMed ID: 11147814
[TBL] [Abstract][Full Text] [Related]
10. Receptor-mediated autocrine growth-stimulatory effect of 5-hydroxytryptamine on cultured human pancreatic carcinoid cells.
Ishizuka J; Beauchamp RD; Townsend CM; Greeley GH; Thompson JC
J Cell Physiol; 1992 Jan; 150(1):1-7. PubMed ID: 1309821
[TBL] [Abstract][Full Text] [Related]
11. Effects of gastrin on 3',5'-cyclic adenosine monophosphate, intracellular calcium, and phosphatidylinositol hydrolysis in human colon cancer cells.
Ishizuka J; Townsend CM; Bold RJ; Martinez J; Rodriguez M; Thompson JC
Cancer Res; 1994 Apr; 54(8):2129-35. PubMed ID: 8174118
[TBL] [Abstract][Full Text] [Related]
12. Characterization of neurotensin-stimulated phosphoinositide hydrolysis in brain regions of long sleep and short sleep mice.
Erwin VG; Radcliffe RA
Brain Res; 1993 Nov; 629(1):59-66. PubMed ID: 7904533
[TBL] [Abstract][Full Text] [Related]
13. Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1.
Guha S; Lunn JA; Santiskulvong C; Rozengurt E
Cancer Res; 2003 May; 63(10):2379-87. PubMed ID: 12750255
[TBL] [Abstract][Full Text] [Related]
14. Increased tumorigenicity in the human pancreatic cell line MIA PaCa-2 is associated with an aberrant regulation of an IGF-1 autocrine loop and lack of expression of the TGF-beta type RII receptor.
Freeman JW; Mattingly CA; Strodel WE
J Cell Physiol; 1995 Oct; 165(1):155-63. PubMed ID: 7559796
[TBL] [Abstract][Full Text] [Related]
15. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2.
Alcock RA; Dey S; Chendil D; Inayat MS; Mohiuddin M; Hartman G; Chatfield LK; Gallicchio VS; Ahmed MM
Oncogene; 2002 Nov; 21(51):7883-90. PubMed ID: 12420225
[TBL] [Abstract][Full Text] [Related]
16. Novel action of transforming growth factor beta 1 in functioning human pancreatic carcinoid cells.
Ishizuka J; Beauchamp RD; Sato K; Townsend CM; Thompson JC
J Cell Physiol; 1993 Jul; 156(1):112-8. PubMed ID: 8391003
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic cancer bears overexpression of neurotensin and neurotensin receptor subtype-1 and SR 48692 counteracts neurotensin induced cell proliferation in human pancreatic ductal carcinoma cell line PANC-1.
Wang JG; Li NN; Li HN; Cui L; Wang P
Neuropeptides; 2011 Apr; 45(2):151-6. PubMed ID: 21272935
[TBL] [Abstract][Full Text] [Related]
18. Neurotensin stimulates inositol phospholipid hydrolysis in rat brain slices.
Goedert M; Pinnock RD; Downes CP; Mantyh PW; Emson PC
Brain Res; 1984 Dec; 323(1):193-7. PubMed ID: 6098333
[TBL] [Abstract][Full Text] [Related]
19. Expression of neurotensin messenger RNA in a human carcinoid tumor.
Evers BM; Ishizuka J; Townsend CM; Rajaraman S; Thompson JC
Ann Surg; 1991 Oct; 214(4):448-54; discussion 454-5. PubMed ID: 1659338
[TBL] [Abstract][Full Text] [Related]
20. Neurotensin and EGF induce synergistic stimulation of DNA synthesis by increasing the duration of ERK signaling in ductal pancreatic cancer cells.
Kisfalvi K; Guha S; Rozengurt E
J Cell Physiol; 2005 Mar; 202(3):880-90. PubMed ID: 15389644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
